Recent Security Class Actions

ARS Pharmaceuticals Inc. Common Stock (NASDAQ: SPRY)

58 Days left to seek lead plaintiff status.

Company Name:ARS Pharmaceuticals Inc. Common Stock
Stock Symbol:NASDAQ: SPRY
Class Period Start:03/09/2026
Class Period End (inclusive):06/24/2026
Filing Deadline:10/05/2026

The complaint alleges defendants provided investors with material information concerning ARS’s expected timeline for expanded insurance coverage for its epinephrine nasal spray, neffy, with CVS Caremark. Defendants’ statements included, among other things, confidence that this coverage would begin on July 1, 2026 and be in place for the summer and back-to-school allergy seasons. 

ARS Pharmaceuticals Inc. Common Stock (NASDAQ: SPRY) Claim Form

This field is for validation purposes and should be left unchanged.
Name(Required)
Address